Research
Hormonal
Longer daytime napping was associated with higher abdominal obesity prevalence (e.g., ≥1 hours: AOR, 1.39; 95% CI, 1.31-1.47).
Reducing the duration of daytime naps may help lower the risk of abdominal obesity.
StrongSupportsmedium confidence
Longer napping was associated with higher abdominal obesity prevalence (eg, ≥1 hours: AOR, 1.39; 95% CI, 1.31-1.47).
Why this rating
Based on the large, multinational, population-based cross-sectional study design.
Source
Timing and Length of Nocturnal Sleep and Daytime Napping and Associations With Obesity Types in High-, Middle-, and Low-Income Countries
Lap Ah Tse et al. · JAMA Network Open · 2021
DOI 10.1001/jamanetworkopen.2021.13775
cross-sectional · n=136652Cited 46×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →